LLYbenzinga

Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth

Summary

A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on November 17, 2024 by benzinga

    Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth | LLY Stock News | Candlesense